Navigation Links
?The MedZilla.com Employment Report for April, 2013: Unemployment Rate Drops as Obama Announces Major Bio-Tech Research Initiative
Date:4/11/2013

Seattle, WA (PRWEB) April 11, 2013

The latest news out of Washington continued to show positive job growth in the economic sector. While the nation's economy continues to improve, many companies are turning to intermediary employment agencies to transition workers from part time and temporary positions into full time employees; up to as much as a third, since the beginning of the year. (challengergray.com, 4/4/13)

Though the unemployment rate steadily declined and consumer confidence has begun to resurge, according to the New York Times, President Obama has agreed to back federal funding, as well as secured private investment, for a biotechnology research project which is expected to revolutionize the field of neuroscience. The endeavor will combine the efforts of three government agencies, the National Institutes of Health, the Defense Advanced Research Projects Agency and the National Science Foundation, as well as other private institutions, to refocus efforts on research specific to the human brain, in an initiative officially called "Brain Research through Advancing Innovative Neurotechnologies" (B.R.A.I.N.).

Some skeptics in the field are concerned it is too early to determine whether the current technologies can keep pace with the projected goals. There are those within the administration who likened the scope of the attempt to the Human Genome Project. (nytimes.com, 4/2/13)

"Historically, it's been a positive move for the overall economy to invest in a solid initiative which excites people and sparks the imagination. At the same time, finding a niche that has a realistic potential for developing new technologies, creating new jobs, as well as getting the public and the private sector working together toward a common good. This has all of those elements. The project itself is very interesting and is something that, even with a moderate amount of success, could do a great deal of good for the nation in a lot of areas. That in itself is something to get excited about!" said Del Johnston, Manager of Client Relations at MedZilla.com.

Experts feel that the plan could lead to the development of new technologies and treatments for diseases like Alzheimer's, epilepsy as well as some traumatic brain injuries. According to the Times' report, supporters feel that the impact of the initiative will have nationwide significance not seen since the government's investment in science and technology research after the Russian launch of the Sputnik satellite. (nytimes.com, 4/2/13)

Experts say that the partnership between the public and private sectors is the perfect combination to get the ball rolling. Already more private institutions are becoming interested in providing computational biology laboratory space, new staff and faculty positions.

One of the research supporters, the Max Planck Florida Institute for Neuroscience's scientific director, CEO, and former professor of neurobiology at the Duke University School of Medicine, Dr. David Fitzpatrick released a statement, "In the last five years, we've only just cracked open the door to technologies that make the impossible finally possible. You can't fix it if you don't know how it works. If we can't get to this detailed level of understanding of brain organization and activity, then we're not going to be in a position to effectively address brain disorders." (fiercebiotechresearch.com, 4/5/13)

John Burkhardt Managing Director of MedZilla.com noted: "This definitely has the potential for some exciting advances as well as another area of job growth in the research and biotechnology job sectors, as well as some other related fields. However, more than that, it’s great to see both public and private investors willing to work together to make that investment."

**********************************************************************************************************
About MedZilla.com:

Established in mid-1994, MedZilla is the original and leading web site to serve career and hiring needs for professionals and employers in biotechnology, pharmaceuticals, medicine, science and healthcare. The MedZilla jobs database contains about 7,500 open positions. The resume database currently contains over 295,000 resumes with 26,500 less than three months old. These resources have been characterized as the largest, most comprehensive databases of their kind on the web in the industries served.

MedZilla(R) is a Registered Trademark owned by MedZilla Inc. Copyright (C)MedZilla, Inc. Permission is granted to reproduce and distribute this text in its entirety, and if electronically, with a link to the URL http://www.medzilla.com. For permission to quote from or reproduce any portion of this message, please contact MedZilla, Inc. at press(at)medzilla(dot)com

Press Inquiries
Contact: MedZilla, Inc.
Phone: (360) 657-5681
press(at)medzilla(dot)com

###

Read the full story at http://www.prweb.com/releases/2013/4/prweb10620953.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Medzilla.com Special Report: Unemployed Can Breathe a Little Freer After Supreme Court's Affordable Care Act Ruling
2. ?The MedZilla.com Employment Report for January, 2013: Wrapping Up the Year in Employment Statistics: Recovery Efforts and the Coming Effects
3. MedZilla.com Launches New Site Design for 2013, Slick New Interface Impresses
4. The MedZilla.com Employment Report for February, 2013: Health Care Sector Stimulates Job Growth Throughout the Recession
5. The Medzilla Employment Report for December, 2012: Unemployment Drops to Lowest Rate in 4 Years; Experts Predict Unprecedented Growth in Healthcare IT
6. BioSpace Releases 2013 Life Sciences / Biotech Employment Outlook
7. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
8. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
10. Interleukin Genetics Reports Third Quarter 2011 Financial Results
11. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)...  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a ... solid tumor cancers, today announced that yesterday it ... last Friday, March 17, 2017. ... totaling 28,843,692 shares, comprised of 18,843,692 common shares ... Class C Warrants pre-funded at the closing at ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... La. (PRWEB) , ... March 23, 2017 , ... ... industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as ... customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has ...
(Date:3/22/2017)... , March 22, 2017 Good Start Genetics, ... has eclipsed the 130 million covered lives mark through ... of Texas . With newly signed ... continues to enjoy strong payor acceptance based on the ... programs and genetic counseling, its industry-leading customer care and ...
Breaking Biology Technology:
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/9/2017)... 9, 2017 The biomass boiler market report ... biomass boiler market globally in terms of revenue (US$ ... The market for biomass boilers has been segmented on ... and country/region. The market based on feedstock type, has ... biogas & energy crops, urban residues, and others. On ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
Breaking Biology News(10 mins):